Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients

BACKGROUND AND AIMS: Chronic hepatitis B (CHB) patients rarely achieve hepatitis B surface antigen (HBsAg) loss with nucleoside/nucleotide analog therapy. METHODS: In this retrospective study, it was evaluated that the rate of HBsAg loss in the HBe antigen negative (HBeAg(−)) patients (n=101) treate...

全面介紹

Na minha lista:
書目詳細資料
發表在:Infect Drug Resist
Main Authors: Yan, Lei, Zhu, Chuanwu, Li, Jing, Chen, Liwen, Ding, Yezhou, Cao, Zhujun, Liu, Kehui, Lin, Lanyi, Tang, Weiliang, Xie, Qing, Xu, Yumin, Bao, Shisan, Wang, Hui
格式: Artigo
語言:Inglês
出版: SAGE Publications 2018
主題:
Original Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6211310/
https://ncbi.nlm.nih.gov/pubmed/30464542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S175707
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍